HF
IBIO icon

HRT Financial’s iBio IBIO Stock Holding History

HRT Financial’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,157
Closed -$28K – 3545
2025
Q3 		$28K Buy
+34,157
New +$26.2K ﹤0.01% 2668
2023
Q4 		– Sell
-3,181
Closed -$19K – 2658
2023
Q3 		$19K Buy
+3,181
New +$27.5K ﹤0.01% 2077
2023
Q1 		– Sell
-601
Closed -$5K – 2785
2022
Q4 		$5K Buy
601
+531
+759% +$18K ﹤0.01% 2270
2022
Q3 		$6K Sell
70
-219
-76% -$30.1K ﹤0.01% 2573
2022
Q2 		$38K Buy
+289
New +$43.4K ﹤0.01% 2538
2021
Q4 		– Sell
-22
Closed -$11K – 3579
2021
Q3 		$11K Buy
+22
New +$13.7K ﹤0.01% 3185

Other funds holding IBIO

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return